Apnicid 40 Injection
Marketer
Ajanta Pharma Ltd
Salt Composition
Pantoprazole (40mg)
Overview Apnicid 40 Injection
Gastric acid production is suppressed by the intravenous medication, AcidGard 40 Injection. Indicated for stomach and intestinal disorders stemming from excess acid, including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, it offers symptomatic relief and facilitates healing. Further uses include preventing stress ulcers in critically ill patients and pre-anesthetic administration to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this injection is administered by a medical professional only when deemed clinically superior to oral formulations. Dosage and treatment length are determined by individual needs and response, and adherence to the prescribed regimen is crucial, even with rapid symptom resolution. Dietary modifications, such as smaller, more frequent meals, and avoidance of caffeine, spicy, and fatty foods, can enhance treatment effectiveness. Common, generally mild, adverse effects comprise nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis. Persistent or bothersome side effects warrant medical attention. Prolonged use, especially exceeding one year or at higher doses, may elevate fracture risk. Discuss bone health preservation strategies, such as calcium and vitamin D supplementation, with your physician. AcidGard 40 Injection is contraindicated in individuals with severe hepatic impairment, those on HIV medication, those with prior allergic reactions to PPIs, and those with pre-existing osteoporosis. Pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption should be avoided due to its acid-stimulating effects. Refrain from operating machinery or driving if experiencing dizziness or drowsiness.
Primary Ingredients of Apnicid 40 Injection
The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Apnicid 40 Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Apnicid 40 Injection:
Administering this medication will be done by your doctor or nurse; self-medication is strictly prohibited.
Common Side effects of Apnicid 40 Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Apnicid 40 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Apnicid 40 Injection works:
Gastric acid secretion is diminished by Apnicid 40 Injection, a proton pump inhibitor (PPI), thus alleviating heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Apnicid 40 Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Apnicid 40 Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Apnicid 40 Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
Apnicid 40 Injection's impact on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Apnicid 40 Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
Patients with significant hepatic impairment should use Apnicid 40 Injection cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Apnicid 40 Injection :
Omitting a scheduled Apnicid 40 Injection requires contacting your physician.
Facts to Know About Apnicid 40 Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | PPIs |



